Get started
Author

Markus Barden

Observed name: M Barden
ORCID: 0000-0002-4923-2254
Observed ORCID: 0000-0002-4923-2254
OpenAlex ID: A5042207171
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
2024 · Jeremy G. Baldwin, Christoph Heuser-Loy, et al. · Cell · 279
The growing world of CAR T cell trials: a systematic review
2016 · Astrid Holzinger, Markus Barden, et al. · Cancer Immunology Immunotherapy · 121
IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
2021 · Andreas Hombach, Markus Barden, et al. · Molecular Therapy · 59
PDF
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
2023 · Dennis Christoph Harrer, Sin-Syue Li, et al. · Frontiers in Immunology · 34
PDF
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function
2024 · Markus Barden, Patrick Ronan Elsenbroich, et al. · Journal for ImmunoTherapy of Cancer · 30
PDF
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation
2023 · Markus Barden, Astrid Holzinger, et al. · Frontiers in Immunology · 27
CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop
2022 · Dennis Christoph Harrer, Charlotte Schenkel, et al. · Cells · 25
PDF
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma
2024 · Krasimira Aleksandrova, Jana Leise, et al. · Frontiers in Immunology · 16
PDF
Magnetic CAR T cell purification using an anti-G4S linker antibody
2024 · Dennis Christoph Harrer, Sin-Syue Li, et al. · Journal of Immunological Methods · 6
Development of antigen multimers for detection and evaluation of CAR T cells
2025 · Rasmus U. W. Friis, Maria Ormhøj, et al. · Cancer Immunology Immunotherapy · 3
PDF
Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion
2025 · Dennis Christoph Harrer, Tim Schlierkamp-Voosen, et al. · Cells · 3
PDF
Drug-controlled CAR T cells through the regulation of cell–cell interactions
2026 · Leo Scheller, Greta Maria Paola Giordano Attianese, et al. · Nature Chemical Biology · 2
PDF
In vivo CAR T cells on the highway: a roadmap for the next decade
2026 · Markus Barden, Dennis C. Harrer, et al. · Expert Opinion on Biological Therapy · 1
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma
2026 · Tim Schlierkamp-Voosen, Markus Barden, et al. · Frontiers in Immunology · 1
PDF
P06.14 Reprogramming CAR-T cells to overcome tumor intrinsic resistance in solid tumors
2026 · M Mukherjee, A Hussein, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release
2024 · Dennis Christoph Harrer, Matthias Eder, et al. · Cancers · 1
Anti-PD-L1 antibody limits the survival of activated CAR T cells by disrupting the PD-L1/CD80 cis-heterodimer
2026 · Sin-Syue Li, Markus Barden, et al. · Frontiers in Immunology
PDF
CAR T cell cancer immunotherapy: who does the job?
2026 · Dennis Christoph Harrer, Markus Barden, et al. · Frontiers in Immunology
PDF
Augmenting CAR T cell functionality and metabolism through CD39 downtuning
2026 · Dennis Christoph Harrer, Jeremy Baldwin, et al. · Molecular Therapy Oncology
Multicenter preclinical validation of next-generation CAR T cells: a strategy for harmonization, reproducibility, and its feasibility in clinical translation
2026 · Iman Dalloul, Markus Barden, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Review Article: Does CAR-T Cell Therapy of Solid Cancer Need the Activation of an Innate Immune Response?
2026 · Markus Barden, Christoph Harrer, et al. · Critical Reviews™ in Oncogenesis
CAR-T-Zellen bei soliden Tumoren – Mechanismen der Resistenz
2025 · Markus Barden, Astrid Holzinger, et al. · Die Innere Medizin
Works count: 22
Citation count: 609
H-index: 8
I10-index: 8
Year
Topic
Type